There are several things you can do to improve your daily routine while living with Parkinson’s. Many of these changes…
Isaura Santos
Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Isaura Santos
Melior Discovery, Inc. has recently announced that the United States Patent and Trademark Office (USTPO) granted the company a…
Senior Helpers, one of the largest home senior care companies in the United States, recently announced it has been named the exclusive sponsor of…
The National Parkinson Foundation (NPF) recently announced that an ongoing national research project comparing telemedicine-based healthcare provided by a Parkinson’s disease center to…
International Stem Cell Corp (ISCO) Uses Revolutionary Technology To Boost Regenerative Medicine
According to the Mayo Clinic, current treatments are often unable to address the medical needs of Parkinson’s patients, since clinicians only have access…
Researchers from the University of Florida have uncovered a biomarker that reveals the progression of Parkinson’s disease in the brain.
Biotie Therapies has announced an agreement with the United States Food and Drug Administration (FDA) on a Special Protocol Assessment…
The Michael J. Fox Foundation for Parkinson’s Research has announced that it is collaborating with The Edmond J. Safra Foundation to select…
According to a recent survey, there is a need for a Parkinson’s disease organization that is committed to and…
Amarantus’ Lead Product For Parkinson’s Disease Receives Notice of Allowance from Patent Office
Amarantus BioScience Holdings, a biotechnology company developing diagnostic and therapeutic products to address neurological disorders and orphan conditions, recently announced it has received a Notice…